Intra-Cellular Therapies Announces Amended Start Time to Virtual Event on Wednesday, October 20

Rhea-AI Summary

Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) announced a Virtual Event on October 20, 2021, from 1:00 p.m. to 4:00 p.m. ET, focusing on its development programs for lumateperone, ITI-1284, PDE1 inhibitors, and ITI-333. The event will be accessible via a webcast on the company's Investor Relations page. Intra-Cellular Therapies specializes in therapeutics for CNS disorders, leveraging Nobel prize-winning research to develop innovative treatments for psychiatric and neurologic diseases.

Webcast to begin at 1:00 p.m. ET

Virtual event to include discussions on our lumateperone, ITI-1284, PDE1 inhibitors, and ITI-333 platforms

NEW YORK, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced the Company’s Virtual Event featuring highlights of its development programs being held on Wednesday, October 20, 2021 will now begin at 1:00 p.m. ET. The virtual event will run from 1:00 p.m. ET – 4:00 p.m. ET.

The live and archived webcast can be accessed under "Events & Presentations" on the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies

Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.

Contact:

Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Lisa Burns
cradinovic@burnsmc.com
212-213-0006

MEDIA INQUIRIES:
Sara Franks
Corporate Media Relations W2O Group
sfranks@w2ogroup.com
410-991-4287

 

FAQ

What is the date of Intra-Cellular Therapies' Virtual Event?

Intra-Cellular Therapies' Virtual Event is scheduled for October 20, 2021.

What will be discussed during the Virtual Event hosted by ITCI?

The Virtual Event will include discussions on lumateperone, ITI-1284, PDE1 inhibitors, and ITI-333 platforms.

What time does the ITCI Virtual Event start?

The ITCI Virtual Event will begin at 1:00 p.m. ET.

How can I access the webcast of the ITCI Virtual Event?

The webcast can be accessed under 'Events & Presentations' on the Investor Relations section of Intra-Cellular Therapies' website.